Page 4 - Medicine Trading Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Medicine trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Medicine Trading Down Today - Breaking & Trending Today

153,257 Shares in Clearmind Medicine Inc. (NASDAQ:CMND) Purchased by AdvisorShares Investments LLC

153,257 Shares in Clearmind Medicine Inc. (NASDAQ:CMND) Purchased by AdvisorShares Investments LLC
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Advisorshares Investments , Clearmind Medicine Inc , Clearmind Medicine , Free Report , Medicine Trading Down , Medicine Inc , Visit Holdingschannel , Clearmind Medicine Daily ,

Editas Medicine (NASDAQ:EDIT) Stock Rating Reaffirmed by Oppenheimer

Oppenheimer restated their market perform rating on shares of Editas Medicine (NASDAQ:EDIT – Free Report) in a research report report published on Thursday morning, Benzinga reports. They currently have a $12.00 price target on the stock. EDIT has been the subject of a number of other research reports. StockNews.com lowered Editas Medicine from a hold […] ....

Baisong Mei , Gilmore Neil Oneill , Raymond James , Congress Asset Management Co , Dimensional Fund Advisors , Silicon Hills Wealth Management , Editas Medicine Company Profile , Securities Exchange Commission , Editas Medicine Inc , Editas Medicine , Free Report , Medicine Trading Down , Get Free Report , Neilo Neill , Exchange Commission , Hills Wealth Management , Asset Management , Fund Advisors , Leber Congenital Amaurosis , Editas Medicine Daily , Nasdaq Edit , Reiterated Rating , Oppenheimer Holdings Inc ,

Chardan Capital Lowers Editas Medicine (NASDAQ:EDIT) Price Target to $19.00

Editas Medicine (NASDAQ:EDIT – Free Report) had its price objective cut by Chardan Capital from $22.00 to $19.00 in a report published on Wednesday morning, MarketBeat Ratings reports. They currently have a buy rating on the stock. EDIT has been the topic of a number of other reports. Raymond James upgraded shares of Editas Medicine […] ....

Gilmore Neil Oneill , Baisong Mei , Raymond James , Dimensional Fund Advisors , Securities Exchange Commission , Editas Medicine Inc , Renaissance Technologies , Blackrock Inc , Editas Medicine , Free Report , Chardan Capital , Marketbeat Ratings , Medicine Trading Down , Get Free Report , Exchange Commission , Neilo Neill , Street Corp , Fund Advisors , Asset Management , Leber Congenital Amaurosis , Editas Medicine Daily , Nasdaq Edit , Lower Price Target ,

Editas Medicine (NASDAQ:EDIT) Stock Rating Upgraded by Raymond James

Raymond James upgraded shares of Editas Medicine (NASDAQ:EDIT – Get Rating) from a market perform rating to an outperform rating in a research note published on Monday morning, The Fly reports. The firm currently has $17.00 target price on the stock. A number of other brokerages have also recently commented on EDIT. Royal Bank of […] ....

Jennifera Doudna , Raymond James , Feng Zhang , Gilmore Neil Oneill , Credit Suisse Group , Securities Exchange Commission , Penserra Capital Management , Allspring Global Investments Holdings , Wells Fargo Company , George Mcdonald Church , Royal Bank , Covestor Ltd , Editas Medicine Inc , Editas Medicine , Get Rating , Suisse Group , Chardan Capital , Medicine Trading Down , Neilo Neill , Exchange Commission , Global Investments Holdings , Editas Medicine Daily ,

Insider Selling: Prime Medicine, Inc. (NYSE:PRME) Major Shareholder Sells $374,647.80 in Stock

Prime Medicine, Inc. (NYSE:PRME – Get Rating) major shareholder 2019 Gp L.L.C. Gv sold 22,434 shares of the company’s stock in a transaction on Monday, June 5th. The shares were sold at an average price of $16.70, for a total value of $374,647.80. The transaction was disclosed in a filing with the Securities & Exchange […] ....

United Kingdom , Securities Exchange Commission , Medicine Inc , Prime Medicine , Get Rating , Exchange Commission , Medicine Trading Down , Prime Medicine Daily ,